Engineers Gate Manager’s Rigel Pharmaceuticals RIGL Stock Holding History

Engineers Gate Manager’s Portfolio RIGL Stock Details RIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$765K	Buy	28,288 +10,056	+55%	+$338K	0.01%	1183
2025 Q4	$781K	Sell	18,232 -7,833	-30%	-$295K	0.01%	1157
2025 Q3	$738K	Buy	+26,065	New	+$780K	0.01%	1320
2025 Q1	–	Sell	-12,609	Closed	-$212K	–	2504
2024 Q4	$212K	Buy	+12,609	New	+$242K	﹤0.01%	1866
2024 Q2	–	Sell	-1,016	Closed	-$15K	–	2181
2024 Q1	$15K	Hold	1,016	–	–	﹤0.01%	1847
2023 Q4	$14.7K	Hold	1,016	–	–	﹤0.01%	1920
2023 Q3	$11K	Sell	1,016 -10	-1%	-$120	﹤0.01%	1725
2023 Q2	$13.2K	Hold	1,026	–	–	﹤0.01%	1677
2023 Q1	$13.5K	Buy	1,026 +10	+1%	+$159	﹤0.01%	1595
2022 Q4	$15.2K	Buy	+1,016	New	+$9.31K	﹤0.01%	1616
2022 Q2	–	Sell	-3,452	Closed	-$103K	–	2205
2022 Q1	$103K	Buy	+3,452	New	+$93.5K	﹤0.01%	1705
2017 Q4	–	Sell	-3,143	Closed	-$80K	–	837
2017 Q3	$80K	Sell	3,143 -3,922	-56%	-$95.4K	0.01%	668
2017 Q2	$193K	Buy	+7,065	New	+$193K	0.02%	598

Other funds holding RIGL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Engineers Gate Manager's RIGL Position: Q1 2026 in Review

Engineers Gate Manager increased its Rigel Pharmaceuticals (RIGL) stake by 55% in Q1 2026, buying an estimated $338K and bringing the position to 28,288 shares worth $765K. The position accounts for 0.01% of the portfolio, ranked #1183.

Engineers Gate Manager first reported a position in RIGL in Q2 2017 and has held it in 13 quarters since. The position peaked at $781K in Q4 2025. 159 funds tracked by Wall St. Rank hold RIGL as of Q1 2026.

Engineers Gate Manager held 28,288 shares of Rigel Pharmaceuticals worth $765K as of Q1 2026.
Engineers Gate Manager bought 10,056 Rigel Pharmaceuticals shares in Q1 2026, an estimated $338K.
Rigel Pharmaceuticals made up 0.01% of Engineers Gate Manager's portfolio in Q1 2026, its #1183 holding.
Engineers Gate Manager first reported a position in Rigel Pharmaceuticals in Q2 2017 and has held it in 13 quarters since.
Engineers Gate Manager's Rigel Pharmaceuticals position peaked at $781K in Q4 2025.
159 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2026.

Based on Engineers Gate Manager's 13F filing for Q1 2026, filed 15 May 2026.